HUGE News and Press, FSD Pharma Inc. From 12/15/23

Industrial & Commercial Bank of China Ltd. ADR (IDCBY) is expected to report for Q3 2023 Air China Ltd ADR - Level I (AIRYY) is expected to report for Q3 2023 Bexil Corp (BXLC) is expected to report for quarter end 2023-09-30 Timberline Resources Corp. (TLRS) is expected to report...

First Republic Bank (San Francisco, California) (FRCB) is expected to report for Q3 2023 GEA Group AG (GEAGF) is expected to report for Q3 2023 Janel Corp (JANL) is expected to report for quarter end 2023-09-30 Screen Holdings Co. Ltd. (DINRF) is expected to report for Q2 2024 Tom...

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) today announced that it has closed a non-brokered private placement and issued 24 class A multiple voting shares of the company, each at a price of $1.90, for gross proceeds of $45.60 (the “offering”). All securities issued pursuant...

TORONTO, ON / ACCESSWIRE / December 5, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (the " Company " or " FSD "), is pleased to announce that, further to its news release on November 27, 2023, it has closed a non-brokered private placement and issued 24 class A multiple voting shares...

Tomra Systems ASA ADR (TMRAY) is expected to report for Q3 2023 China Minsheng Banking Corporation Ltd. ADR (CMAKY) is expected to report for quarter end 2023-09-30 Taisei Corporation ADR (TISCY) is expected to report for Q2 2024 Spark New Zealand Limited ADR (SPKKY) is expected to re...

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) and Celly Nutrition Corp. (“Celly Nu”) today announced the closing of the previously proposed distribution of a portion of FSD Pharma’s holdings of common shares of Celly Nu (“Celly Nu shares”) to certain securi...

TORONTO, ON / ACCESSWIRE / November 30, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (" FSD Pharma " or the " Company) and Celly Nutrition Corp. (" Celly Nu ") are pleased to announce the closing of the previously announced proposed distribution of a portion of FSD Pharma's holdings...

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions. The company has issued a statement as an update regarding its litigation with GBB Drink Lab Inc. previously referenced at: FSD Pharma Re...

TORONTO, ON / ACCESSWIRE / November 28, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (" FSD Pharma " or the " Company "), is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions. The Company is providing this statement as an update ...

2023-11-27 08:51:16 ET More on FSD Pharma Financial information for FSD Pharma For further details see: FSD Pharma obtains final order for plan of arrangement from Ontario court